-
Alarm bells ring again!
Time of Update: 2022-08-15
According to relevant laws and regulations, the Henan Provincial Food and Drug Administration issued a warning to the company and fined 160,000 yuan .
According to relevant laws and regulations, the Henan Provincial Food and Drug Administration issued a warning to the company and fined 160,000 yuan .
-
A batch of medical device registration certificates have been cancelled!
Time of Update: 2022-08-15
On April 21, the Henan Provincial Drug Administration issued an announcement (No. 46, 2022) on the cancellation of the registration certificate of medical device products, stating that in accordance with the "Regulations on the Supervision and Administration of Medical Devices", according to the application of the enterprise, Yuan (Henan) is now cancelled.
-
A large number of enterprises take the initiative to cancel the "Medical Device Registration Certificate"!
Time of Update: 2022-08-15
[Pharmaceutical Network Industry News] On August 2, the State Food and Drug Administration announced that in accordance with the relevant provisions of the "Regulations on the Supervision and Administration of Medical Devices", according to the application of enterprises, the registration certificates of medical devices for 6 products are now cancelled .
-
【Shichen】Enter a high-tech enterprise——Topchain Pharma/Topchain Pharma
Time of Update: 2022-08-15
sample application Microcrystalline cellulose, pellet core, co-processing Scan the code to receive samples Dongchen Pharmaceutical The company integrates research and development, production and sales, with the goal of building an internationally renowned and domestic leading modern high-tech enterprise and service provider.
-
The seventh batch of national arrows is on the line, in-depth analysis of the competition pattern of pharmaceutical companies
Time of Update: 2022-08-15
The rules are basically mature and steadily advancing After three years and six batches of practice in the national centralized procurement, the rules are constantly improving, and a basic institutional framework for normalization and institutionalization has been formed, including three levels: First, price discovery is carried out through the national centralized procurement bidding process, and the price is bottomed out on the premise of ensuring the reasonable profits of the enterprise .
-
The pharmaceutical industry is facing a big shock!
Time of Update: 2022-08-15
. For example, some time ago, Sihuan Pharmaceutical announced that it plans to propose to sell some or all of its generic drugs and other non-core traditional medicine businesses that have not met performance expectations or long-term strategic goals due to the impact of changes in the pharmaceutical industry and policies.
-
On the same day, there were major changes in the executives of many pharmaceutical companies
Time of Update: 2022-08-15
For example, AstraZeneca also issued an internal announcement in April this year: Lu Yanbin, the current deputy director of the Strategic Project Management Office, will leave the company to seek external development opportunities due to personal reasons .
-
Another pharmaceutical company has been intensively investigated by the organization!
Time of Update: 2022-08-15
. Among the blockbuster products, HP518, a new drug for the treatment of drug-resistant prostate cancer, was independently developed and successfully promoted to enter Phase I clinical trials in Australia, and achieved the first patient administration (FIH).
-
32 pharmaceutical companies raised more than 30 billion yuan!
Time of Update: 2022-08-15
5 billion yuan, which will be invested in projects such as global headquarters and innovation and industrialization bases, peripheral vascular intervention and tumor intervention medical device research and development, and replenishment of working capital For example, Xinmai Medical announced on July 25 that it has launched a fixed increase plan of 2.
-
Priority introduction and price exposure, the new crown neutralizing antibody welcomes the highlight moment?
Time of Update: 2022-08-15
3 New crown neutralizing antibody research and development is hot More than 30 domestic enterprises are deployed According to incomplete statistics, there are 7 types of COVID-19 neutralizing antibody therapies on the market globally, namely Casirizumab + Idezumab from Roche and Regeneron, and Atelizumab + Banivirumab from Eli Lilly.
-
The national centralized procurement has saved a total of 300 billion!
Time of Update: 2022-08-15
On July 22, the National Health and Health Commission held a press conference. The responsible comrades of the National Health and Health Commission, the National Development and Reform Commission, t
-
Chain pharmacies are about to enter the "10,000-store era", and the "big eats" and "big eats" mergers and acquisitions are accelerating
Time of Update: 2022-08-15
have basically completed the online channel layout At present, leading chain pharmacies including Yixintang, Common People, Yifeng Pharmacy, Dashenlin, Jianzhijia, Shuyu Civilian, etc.
-
There are 12 self-paid medicines in the collection of 18 varieties!
Time of Update: 2022-08-15
. It is worth mentioning that both diosmin and compound α-ketoacid are clearly required for oral normal-release dosage forms in the bulk purchase of eight provinces and two districts, but the current problem is that these two varieties of tablets The medicine belongs to the national medical insurance, while the capsule belongs to the non-medical insurance .
-
Aiming at the broad domestic pharmaceutical equipment market, the construction of new projects for pharmaceutical machine companies is in full swing
Time of Update: 2022-08-15
. Taking Chutian Technology as an example, it announced on August 2 that the company intends to jointly fund the establishment of a company in Ningxiang City, Changsha, Hunan Province to provide medical equipment, medical equipment, mechanical engineering and other related industries with a team of experts in the precision manufacturing industry.
-
The consistency evaluation of 513 varieties of generic drugs has passed the review, and since July, there have been many products from pharmaceutical companies.
Time of Update: 2022-08-15
. Recently, Yuan Lin, director of the Drug Supervision Department of the State Food and Drug Administration, introduced that as of now, the State Food and Drug Administration has reviewed and approved 513 varieties of generic drug consistency evaluation applications involving 2,555 product specifications, and the quality of the listed generic drugs has been continuously improved.
-
Policy review: how provincial medical insurance policies inject new momentum into the development of traditional Chinese medicine
Time of Update: 2022-08-15
Gansu Province proposed to promote the development of "smart Chinese pharmacies", improve the level of pharmaceutical services such as TCM decoction pieces and formulations, and realize the integration of TCM decoction pieces procurement and storage, prescription circulation, medical insurance settlement, preparation and decoction, centralized distribution, and quality management in medical institutions.
-
Starting this month, more than 300 traditional Chinese medicine formula granules will be included in medical insurance
Time of Update: 2022-08-15
Dynamic adjustment In the next step, the Anhui Provincial Medical Insurance Bureau will also work with the Provincial Department of Human Resources and Social Security and the Provincial Drug Administration in accordance with the national standards for traditional Chinese medicine formula granules and the release of Anhui provincial standards, combined with clinical actual use and other factors, to implement the traditional Chinese medicine formula granules included in the fund payment scope.
-
High-tech regular bacteria Yieryou has a new action! Liquid probiotics are about to shock the market
Time of Update: 2022-08-15
At that time, Zhongweiyuan Biotechnology will Yieryou active probiotic drink was released It is understood that on May 18, the 2022 China Probiotics Industry Development Summit Forum, hosted by the People's Government of Longzihu District, Bengbu, Anhui, and the China Health Care Association, and co-organized by Zhongweiyuan Biotechnology, will be held at the Bengbu Radio and Television Station, Anhui Province.
-
The eve of bid opening!
Time of Update: 2022-08-15
The criteria for determining the companies to be selected in this centralized procurement continue the previous principle of price reduction (see Scenario 1 below), but the specific rules are more detailed (see Scenario 2 below) .
-
It is not easy for domestic new drugs to go overseas, this pharmaceutical company initiated another breakthrough!
Time of Update: 2022-08-15
It is not easy for domestic new drugs to go overseas In March this year, Innovent announced that the “going overseas” had failed, and the marketing application of its core product sintilimab was not approved by the US FDA .